[HTML][HTML] Association of obesity with COVID-19 severity and mortality: an updated systemic review, meta-analysis, and meta-regression

R Singh, SS Rathore, H Khan, S Karale… - Frontiers in …, 2022 - frontiersin.org
Background Obesity affects the course of critical illnesses. We aimed to estimate the
association of obesity with the severity and mortality in coronavirus disease 2019 (COVID …

[HTML][HTML] Vaccine development throughout history

A Saleh, S Qamar, A Tekin, R Singh, R Kashyap - Cureus, 2021 - ncbi.nlm.nih.gov
The emergence of the coronavirus disease 2019 (COVID-19) pandemic has made us
appreciate how important it is to quickly develop treatments and save lives. The race to …

[HTML][HTML] Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19

AD Santin, DE Scheim, PA McCullough… - New Microbes and New …, 2021 - Elsevier
Abstract In 2015, the Nobel Committee for Physiology or Medicine, in its only award for
treatments of infectious diseases since six decades prior, honoured the discovery of …

[HTML][HTML] Non-effectiveness of ivermectin on inpatients and outpatients with COVID-19; results of two randomized, double-blinded, placebo-controlled clinical trials

MS Rezai, F Ahangarkani, A Hill, L Ellis… - Frontiers in …, 2022 - frontiersin.org
Background Ivermectin which was widely considered as a potential treatment for COVID-19,
showed uncertain clinical benefit in many clinical trials. Performing large-scale clinical trials …

[HTML][HTML] Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review. Ivermectin's suggested benefits are mainly based on potentially …

A Izcovich, S Peiris, M Ragusa, F Tortosa… - Journal of Clinical …, 2022 - Elsevier
Objective: The objective of this systematic review is to summarize the effects of ivermectin for
the prevention and treatment of patients with COVID-19 and to assess inconsistencies in …

Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection

R Cobos-Campos, A Apiñaniz, N Parraza… - Current Research in …, 2021 - Elsevier
Purpose of the study Currently no treatment has been proven to be efficacious for patients
with early symptoms of COVID-19. Although most patients present mild or moderate …

Identification and development of therapeutics for COVID-19

HM Rando, N Wellhausen, S Ghosh, AJ Lee… - Msystems, 2021 - Am Soc Microbiol
After emerging in China in late 2019, the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …

[HTML][HTML] Rapid increase of SpO2 on room air for 34 severe COVID-19 patients after ivermectin-based combination treatment: 55-62% normalization within 12-24 hours

JC Stone, P Ndarukwa, DE Scheim, BM Dancis… - 2021 - europepmc.org
Background:. The emergence of COVID-19 in March 2020 challenged Zimbabwe to mount a
response with limited medical facilities and therapeutic options. Ivermectin (IVM) had by then …

Effect of combined use of ivermectin and colchicine in COVID-19 patients

RG El Sayed, AF Hafez… - Egyptian Journal of …, 2022 - Taylor & Francis
Background Despite the great results of the SARS-CoV-2 vaccine, there is an increasing
need for effective therapeutics. Increasing viral loads are associated with systemic …

Potential of anthelmintic herbal drugs against gastrointestinal nematodes in farm animals: A review

S Sadr, PA Simab, M Kasaei, MG Landi… - Farm Animal Health …, 2022 - fahn.rovedar.com
Gastrointestinal (GI) nematode infections are one of the most prevalent and significant
problems in livestock worldwide. This study aimed to review the potential of anthelmintic …